Long-Term Drug Survival and Effectiveness of Secukinumab in Patients with Moderate to Severe Chronic Plaque Psoriasis: 42-Month Results from the SUPREME 2.0 Study
Determinants of Admission to Critical Care Following Acute Recreational Drug Toxicity: A Euro-DEN Plus Study.
Autorzy:
Noseda R; Division of Clinical Pharmacology and Toxicology, Institute of Pharmacological Sciences of Southern Switzerland, Ente Ospedaliero Cantonale, 6900 Lugano, Switzerland. FranchiM; Unit of Biostatistics, Epidemiology and Public Health, Department of Statistics and Quantitative Methods, University of Milano-Bicocca, 20126 Milan, Italy.; National Centre for Healthcare Research and Pharmacoepidemiology, University of Milano-Bicocca, 20126 Milan, Italy. Pagnamenta A; Clinical Trial Unit, Ente Ospedaliero Cantonale, 6900 Lugano, Switzerland.; Department of Intensive Care, Ente Ospedaliero Cantonale, 6900 Lugano, Switzerland.; Division of Pneumology, University of Geneva, 1211 Geneva, Switzerland. Müller L; Division of Clinical Pharmacology and Toxicology, Institute of Pharmacological Sciences of Southern Switzerland, Ente Ospedaliero Cantonale, 6900 Lugano, Switzerland. Dines AM; Clinical Toxicology, Guy's and St Thomas' NHS Foundation Trust and King's Health Partners, London SE1 7EH, UK. Giraudon I; European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), 1249-289 Lisbon, Portugal. Heyerdahl F; Prehospital Division, Oslo University Hospital, 0424 Oslo, Norway.; The Norwegian Air Ambulance Foundation, 0184 Oslo, Norway. Eyer F; Department of Clinical Toxicology, Klinikum Rechts der Isar, Technical University of Munich, 81675 Munich, Germany. Hovda KE; The Norwegian CBRNE Centre of Medicine, Oslo University Hospital, 0450 Oslo, Norway. Liechti ME; Clinical Pharmacology and Toxicology, University Hospital and University of Basel, 4056 Basel, Switzerland. Miró Ò; Emergency Department, Hospital Clínic, University of Barcelona, 08036 Catalonia, Spain. Vallersnes OM; Department of General Practice, University of Oslo, 0318 Oslo, Norway.; Oslo Accident and Emergency Outpatient Clinic, City of Oslo Health Agency, 0182 Oslo, Norway. Yates C; Emergency Department and Clinical Toxicology Unit, Hospital Universitario Son Espases, 07120 Mallorca, Spain. Dargan PI; Clinical Toxicology, Guy's and St Thomas' NHS Foundation Trust and King's Health Partners, London SE1 7EH, UK.; Clinical Toxicology, Faculty of Life Sciences and Medicine, King's College London, London WC2R 2LS, UK. Wood DM; Clinical Toxicology, Guy's and St Thomas' NHS Foundation Trust and King's Health Partners, London SE1 7EH, UK.; Clinical Toxicology, Faculty of Life Sciences and Medicine, King's College London, London WC2R 2LS, UK. Ceschi A; Division of Clinical Pharmacology and Toxicology, Institute of Pharmacological Sciences of Southern Switzerland, Ente Ospedaliero Cantonale, 6900 Lugano, Switzerland.; Clinical Trial Unit, Ente Ospedaliero Cantonale, 6900 Lugano, Switzerland.; Faculty of Biomedical Sciences, Università della Svizzera Italiana, 6900 Lugano, Switzerland.; Department of Clinical Pharmacology and Toxicology, University Hospital Zurich, 8091 Zurich, Switzerland.
Developing a comorbidity score in cancer patients using healthcare utilization databases during the COVID-19 pandemic: An experience from Italy.
Autorzy:
Lasalvia P; Evaluative Epidemiology Unit, Department of Epidemiology and Data Science, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. Trama A; Evaluative Epidemiology Unit, Department of Epidemiology and Data Science, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. Botta L; Evaluative Epidemiology Unit, Department of Epidemiology and Data Science, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. FranchiM; National Centre for Healthcare Research and Pharmacoepidemiology, University of Milano-Bicocca, Milan, Italy.; Unit of Biostatistics, Epidemiology and Public Health, Department of Statistics and Quantitative Methods, University of Milano-Bicocca, Milan, Italy. Bernasconi A; Evaluative Epidemiology Unit, Department of Epidemiology and Data Science, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2023 Apr; Vol. 12 (8), pp. 9849-9856. Date of Electronic Publication: 2022 Dec 20.
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies
